Fuel Performance Solutions (IFUE) 10-K 30 Mar 16 2015 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2015	Mar. 30, 2016	Jun. 30, 2015
Document And Entity Information
Entity Registrant Name	FUEL PERFORMANCE SOLUTIONS, INC.
Entity Central Index Key	1,078,723
Document Type	10-K
Document Period End Date	Dec. 31, 2015
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Public Float			$ 11,267,375
Entity Common Stock, Shares Outstanding		203,758,698
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2,015

BALANCE SHEETS

BALANCE SHEETS - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Current assets
Cash and cash equivalents	$ 25,609	$ 530,201
Accounts receivable, net	20,476	338,572
Inventory	10,750	80,247
Deferred financing cost	57,877	127,555
Prepaid expenses and other assets	27,112	38,937
Total Current Assets	141,824	1,115,512
Goodwill	2,211,805	2,211,805
Total assets	2,353,629	3,327,317
Current liabilities
Accounts payable	287,221	$ 507,044
Convertible notes payable, net of discount of $92,803 and $0, respectively	999,697
Convertible note payable - related party, net of discount of $4,885 and $0, respectively	52,615
Accrued interest	158,997
Accrued interest - related party	8,368
Accrued compensation	937,141	$ 787,026
Derivative liability	425,035	457,380
Other accrued expenses	190,000	190,000
Total current liabilities	$ 3,059,074	1,941,450
Long-term liabilities
Convertible notes payable, net of discount of $0 and $550,975, respectively		541,525
Convertible notes payable - related party, net of discount of $0 and $28,999, respectively		$ 28,501
Notes payable, net of discount of $175,823 and $0, respectively	$ 194,177
Notes payable - related party, net of discount of $15,243 and $0, respectively	29,757
Accrued interest	12,874	$ 39,917
Accrued interest - related party	1,565	2,101
Deferred rent	6,428	10,028
Deferred income taxes	723,000	723,000
Total Long-term Liabilities	967,801	1,345,072
Total Liabilities	4,026,875	3,286,522
Stockholders' equity (deficit)
Common stock, $0.01 par value; 350,000,000 shares authorized; 203,758,698 (net of 1,440,000 shares held in treasury stock) shares issued and outstanding at both December 31, 2015 and 2014	2,051,987	2,051,987
Treasury stock	(664,600)	(664,600)
Discount on common stock	(819,923)	(819,923)
Additional paid-in capital	72,471,486	72,258,932
Accumulated deficit	(74,712,196)	(72,785,601)
Total stockholders' equity (deficit)	(1,673,246)	40,795
Total liabilities and stockholders' equity (deficit)	$ 2,353,629	$ 3,327,317

BALANCE SHEETS (Parenthetical)

BALANCE SHEETS (Parenthetical) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Balance Sheets Parenthetical
Convertible notes payable, discount	$ 92,803	$ 0
Convertible notes payable - discount	4,885	0
Convertible notes payable, net of discount	0	550,975
Convertible notes payable - related party, net of discount	0	28,999
Notes payable, net of discount	175,823	0
Notes payable - related party, net of discount	$ 15,243	$ 0
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	350,000,000	350,000,000
Common stock, shares issued	203,758,698	203,758,698
Common stock, shares outstanding	203,758,698	203,758,698
Treasury stock, shares	1,440,000	1,440,000

STATEMENTS OF OPERATIONS

STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Statements Of Operations
Net Revenues	$ 455,932	$ 1,726,619
Operating expenses
Cost of operations	396,380	1,269,081
Selling, general and administrative expense	$ 1,417,028	4,685,844
Research and development expense		24,090
Gain on accounts payable write off		(59,899)
Gain on deferred revenue write off		(2,998,242)
Total operating expenses	$ 1,813,408	2,920,874
Net loss from operations	(1,357,476)	(1,194,255)
Interest expense, net	(793,345)	(191,247)
Gain on derivative liability	$ 224,226	114,848
Loss on conversion of debt from related party		(387,500)
Net loss before income taxes	$ (1,926,595)	(1,658,154)
Net loss	$ (1,926,595)	$ (1,658,154)
Basic and diluted net loss per common share	$ (0.01)	$ (0.01)
Weighted-average common shares outstanding, basic and diluted	203,758,698	196,487,778

STATEMENTS OF STOCKHOLDERS' EQU

STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)	Common Stock	Treasury Stock	Discount on Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Beginning Balance, Shares at Dec. 31, 2013	159,720,604
Beginning Balance, Amount at Dec. 31, 2013	$ 1,597,206	$ (664,600)	$ (819,923)	$ 67,949,067	$ (71,127,447)	$ (3,065,697)
Issuance of stock for cash, Shares	31,978,094
Issuance of stock for cash, Amount	$ 319,781			516,274		836,055
Issuances of stock for services, Shares	1,000,000
Issuances of stock for services, Amount	$ 10,000			60,000		70,000
Issuance of stock for conversion of debt from related parties, Shares	12,500,000
Issuance of stock for conversion of debt from related parties, Amount	$ 125,000			812,500		937,500
Expense relating to stock option grants				$ 2,921,091		2,921,091
Net loss					$ (1,658,154)	(1,658,154)
Ending Balance, Shares at Dec. 31, 2014	205,198,698
Ending Balance, Amount at Dec. 31, 2014	$ 2,051,987	$ (664,600)	$ (819,923)	$ 72,258,932	$ (72,785,601)	40,795
Expense relating to stock option grants				148,767		$ 148,767
Cancellation of 2015 Affiliate Shares (See Note 7), Shares	(2,075,000)
Cancellation of 2015 Affiliate Shares (See Note 7), Amount	$ (20,750)			20,750
Issuance of 2015 Affiliate Shares (See Note 7), Shares	2,075,000
Issuance of 2015 Affiliate Shares (See Note 7), Amount	$ 20,750			$ 43,037		$ 63,787
Net loss					$ (1,926,595)	(1,926,595)
Ending Balance, Shares at Dec. 31, 2015	205,198,698
Ending Balance, Amount at Dec. 31, 2015	$ 2,051,987	$ (664,600)	$ (819,923)	$ 72,471,486	$ (74,712,196)	$ (1,673,246)

STATEMENTS OF CASH FLOWS

STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Cash flows from operating activities:
Net loss	$ (1,926,595)	$ (1,658,154)
Adjustments to reconcile net loss to net cash used in operating activities:
Bad debt provision	$ 13,735	170,875
Non-cash stock-based compensation		70,000
Non-cash option expense	$ 148,767	2,921,091
Gain on deferred revenue write off		$ (2,998,242)
Loss on inventory write off	$ 44,518
Gain on derivative liability	$ (224,226)	$ (114,848)
Gain on accounts payable write off		(59,899)
Loss on conversion of debt from a related party		387,500
Amortization of debt discount	$ 534,112	112,704
Amortization of deferred financing cost	119,553	36,995
Change in assets and liabilities:
Accounts receivable	304,361	(498,666)
Inventory	24,979	(46,463)
Prepaid expenses and other assets	11,825	(10,653)
Accounts payable	(219,823)	215,959
Accrued interest payable	131,954	39,917
Accrued interest payable - related party	7,833	2,101
Accrued compensation	185,115	44,561
Deferred rent	(3,600)	(2,545)
Net cash used in operating activities	$ (847,492)	(1,387,767)
Cash flows from financing activities:
Gross proceeds from issuance of convertible notes		950,000
Gross proceeds from issuance of convertible notes - related party		$ 50,000
Gross proceeds from issuance of notes payable	$ 370,000
Gross proceeds from issuance of notes payable - related party	10,000
Payments made for deferred financing cost	$ (37,100)	$ (135,000)
Proceeds from issuance of common stock		836,055
Net cash provided by financing activities	$ 342,900	1,701,555
Net increase (decrease) in cash and cash equivalents	(504,592)	313,288
Cash and cash equivalents, beginning	530,201	216,913
Cash and cash equivalents, ending	$ 25,609	$ 530,201
Supplemental disclosure of cash flow information:
Cash paid during the year ended December 31: Interest
Cash paid during the year ended December 31: Income taxes
Non-cash transactions:
Conversion of related party notes to common stock		$ 550,000
Debt discount due to derivative liability		295,773
Debt discount due to derivative liability on warrants issued with convertible notes		$ 246,905
Debt discount due to derivative liability on warrants issued with notes payable	$ 179,106
Convertible note original issuance cost		$ 150,000
Deferred financing cost due to derivative liability for warrants	$ 12,775	$ 29,550
Debt discount due to Affiliate Shares issued with notes payable	63,787
Notes payable issued for accrued compensation	$ 35,000

Nature of Business and Signific

Nature of Business and Significant Accounting Policies	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Note 1 - Nature of Business and Significant Accounting Policies	Nature of Business Fuel Performance Solutions, Inc. (the "Company," "we," "us" or "our") is a company that was incorporated under the laws of the State of Nevada on April 9, 1996. On February 5, 2014, the Company changed its name from International Fuel Technology, Inc. to Fuel Performance Solutions, Inc. We have developed a family of fuel additive product formulations. These unique fuel blends have been created to improve fuel economy, enhance lubricity (reducing engine wear and tear) and lower harmful engine emissions, while decreasing reliance on petroleum-based fuels through the use of more efficient, alternative and renewable fuels. We began transitioning from a development stage technology company to a commercial entity during 2002 and have been increasing our product marketing and sales efforts since. We are now focused on continuing to develop the body of evidence of the efficacy of our products applicable to a wide range of markets and industries within these markets through additional industry specific laboratory testing and customer field-based demonstration testing. In addition, we are continuing to strengthen our distributor and customer contact base. Marketing and sales efforts, in conjunction with the additional industry specific testing, will complete our transition to a commercial enterprise. During 2015, our net revenues were split in the following manner: 8% to United States end-user customers and 92% to international distributors and end-user customers. 80% of our net revenues for 2015 were concentrated among 1 customer. During 2014, our net revenues were split in the following manner: 3% to United States end-user customers and 97% to international distributors and end-user customers. 88% of our net revenues for 2014 were concentrated among 2 customers. At December 31, 2015, 100% of our accounts receivable balance was attributable to 1 customer. At December 31, 2014, 82% of our accounts receivable balance was attributable to 4 customers. Customers whose revenues exceeded 10% of our total revenues for 2015 and 2014 are listed below: Customer Name 2015 2014 Nordmann, Rassmann 80 % 75 % Unipart Group NA 13 % Net revenues related to shipments into various foreign countries were $417,532 and $1,669,037 during 2015 and 2014, respectively. The following table breaks out net revenues by foreign country: Country 2015 2014 Czech. Republic $ 71,806 $ 127,980 Cyprus - 5,665 France 38,919 29,843 Germany 290,658 1,103,970 Romania - 68,336 United Kingdom 16,149 333,243 $ 417,532 $ 1,669,037 We currently utilize Brenntag AG ("Brenntag) as our contracted product manufacturer. Brenntag independently purchases required raw materials to manufacture our product. For the years ended December 31, 2015 and 2014, 100% of our product manufacturing has been handled by Brenntag. Summaries of our significant accounting policies follow: Use of Estimates in the Preparation of Financial Statements The preparation of financial statements in conformity with United States generally accepted accounting principles ("GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Concentration of Credit Risk Financial instruments which potentially subject the Company to concentrations of credit risk consist of cash and trade receivables. We place our cash with high credit quality financial institutions. At times such cash may be in excess of the Federal Deposit Insurance Corporation ("FDIC") limit. With respect to trade receivables, we routinely assess the financial strength of our customers and, as a consequence, believe that our receivable credit risk exposure is limited. Related Parties A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests is also a related party. Revenue Recognition We recognize revenue from the sale of our products when the price is fixed and determinable, persuasive evidence of an arrangement exists, the products are shipped, and title and risk of loss has passed to the buyer and collectability of the resulting receivable is reasonably assured. A majority of our revenues is from sales to product distributors. Product distributors do not have the option to return product that is not immediately sold to an end-user. Therefore, our revenue recognition is not conditional on whether a distributor is able to sell product to an ultimate product end-user. Our sales policies for end-users are consistent with product distributor sales policies. Beginning in May 2013, as an effort to address our outstanding payable balance with and at the request of our product manufacturer, our non-United States customers began remitting receivable payments directly to our product manufacturer in lieu of remitting payment directly to us. Under this arrangement, we still maintained the risks and benefits related to sending the product to each customer and thus recorded sales revenues (and associated cost of sales) applying the gross reporting treatment for each transaction pursuant to the Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") ASC 605-45, " Principal Agent Considerations." Cash and Cash Equivalents Cash and cash equivalents include cash on hand and temporary investments with a maturity of three months or less. We maintain cash in a bank account, which, at times, exceeds federally insured limits. We have experienced no losses relating to these excess amounts of cash in a bank. We utilize a cash management program that assesses daily cash requirements. Excess funds are invested in overnight repurchase agreements backed by United States Treasury securities. Repurchase agreements are not deposits, are not insured or guaranteed by the United States government, the FDIC or any other government agency, and involve investment risk including possible loss of principal. In addition, during 2014, we established a bank facility that has the functionality to hold cash in various international denominations. As of December 31, 2015, we did not have any cash balances held in international denominations and therefore no marking-to-market was required. As of December 31, 2014, we only had international funds held in euros. The balance of this euro account was marked-to-market as of December 31, 2014. Accounts Receivable An allowance for doubtful accounts is maintained at a level we believe sufficient to cover potential losses based on historical trends and known current factors impacting our customers. We have determined that an allowance for doubtful accounts was not necessary as of December 31, 2015 and 2014. We did, however, write off $13,735 and $170,875 of accounts receivable that was expensed in 2015 and 2014, respectively. Inventory Inventory, which consists solely of finished product, is valued at the lower of cost or market, based on the first-in, first-out ("FIFO") method, or market, and reflects the purchased cost from vendors. Although we maintain minimal inventory levels in the United States at external storage facilities, the majority of our inventory is manufactured based on customer demand and immediately shipped to customers upon completion. The raw material components required to manufacture our products reside at our product manufacturer's facilities and are not owned by us. During 2015, we wrote off $44,518 of certain inventory, primarily in the United States, which has sat idle for at least a one-year period. In the event that such inventory is subsequently sold to customers, we will record a gain on the recovery of inventory sold to customers. See Note 13. Inventory Write Off to our financial statements. Goodwill We account for goodwill and intangible assets in accordance with ASC 350 "Intangibles-Goodwill and Other" We completed an evaluation of goodwill at December 31, 2015 and 2014 and determined that there was no impairment. We employed a qualitative evaluation for the 2015 and 2014 analyses. Income Taxes We account for income taxes utilizing ASC 740, "Income Taxes." Research and Development Research and development costs are expensed as incurred. Expense for services received from external vendors for 2015 and 2014 was $0 and $24,090, respectively. Advertising Expenses Advertising costs are expensed as incurred and amounted to $16,735 and $173,763 in 2015 and 2014, respectively. Basic and Diluted Net Earnings (Loss) Per Common Share We account for earnings per share pursuant to ASC 260, " Earnings per Share Derivative Financial Instruments We evaluate our financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in our statements of operations. For stock-based derivative financial instruments, we use a Lattice Model option pricing model, in accordance with ASC 815-15, "Derivatives and Hedging," Fair Value of Financial Instruments We measure our financial assets and liabilities in accordance with the requirements of ASC 820, "Fair Value Measurements and Disclosures." Level 1 - Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities. Level 2 - Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars. Level 3 - Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management's best estimate of fair value. The following table sets forth by level within the fair value hierarchy our financial assets and liabilities that were accounted for at fair value as of December 31, 2015, and December 31, 2014: Recurring Fair Value Measures Level 1 Level 2 Level 3 Total December 31, 2015 Derivative liability $ - $ - $ 425,035 $ 425,035 December 31, 2014 Derivative liability $ - $ - $ 457,380 $ 457,380 Employee Stock-Based Compensation We account for stock-based compensation in accordance with ASC 718, " Compensation-Stock Compensation Non-Employee Stock-Based Compensation We account for stock-based compensation in accordance with the provision of ASC 505, "Equity Based Payments to Non-Employees" Recently Issued Accounting Pronouncements Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on our financial statements.

Substantial Doubt About Ability

Substantial Doubt About Ability to Continue as a Going Concern	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Note 2 - Substantial Doubt About Ability to Continue as a Going Concern	Our financial statements are presented on the going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. We have incurred significant losses since inception and currently have and previously from time to time have had limited funds with which to operate. These conditions raise substantial doubt as to the Company's ability to continue as a going concern. Management is in the process of executing a strategy based upon marketing technologies that offer enhanced engine performance and greater fuel economy along with pollution control benefits. We have been funded since inception primarily by unregistered sales of Company restricted stock, generally to existing shareholders. We have also relied on a $1,000,000 equity commitment from one of our Directors, Rex Carr, of which $500,000 remains available (See Note 5. Equity Commitment and Related Party Transactions to our financial statements). Rex Carr passed away on April 27, 2015. On April 30, 2015, the Company elected Glenn Carr as a Director to its Board of Directors (the "Board"). Glenn Carr is the son of Rex Carr. The Company believes that the equity commitment of Rex Carr will be honored by his estate. However, we can make no assurances as to the timing of when the estate may be settled, and how much we may receive once the estate is settled. In addition, during the third quarter of 2014, we obtained additional funding in the form of a convertible notes payable (see Note 6. Convertible Notes Payable to our financial statements) and during the third quarter of 2015, we obtained additional funding in the form of a subordinated notes payable (see Note 7. Notes Payable to our financial statements). We also obtained funding in the first quarter of 2016 in the form of subordinated notes (see Note 15. Subsequent Events to our financial statements). We are currently in discussions with our investment banker and a number of potential investors to raise additional capital. We believe we will be successful in raising additional capital to fund our operations, but if we are unable to secure additional capital, we will need to curtail operations. The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern.

Stockholders' Equity (Deficit)

Stockholders' Equity (Deficit)	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Note 3 - Stockholders' Equity (Deficit)	On May 22, 2014, we filed a certificate of amendment to our Articles of Incorporation increasing the number of our authorized shares from 250,000,000 to 350,000,000 shares with the Nevada Secretary of State. Effective October 27, 1999, we merged with Blencathia Acquisition Corporation ("Blencathia"). Blencathia was a public shell company with immaterial assets and liabilities and 312,000 shares outstanding at the time of the merger, which it redeemed and cancelled upon the merger. In exchange, we issued 312,000 of our common shares to the prior Blencathia owner with the contractual understanding that such shares were to be sold by that owner to achieve gross cash proceeds of $500,000. Any excess proceeds were to be returned to us and any deficiency was to be made up by us issuing additional shares or paying the difference in cash. As we believed that we controlled the ultimate timing of the sale of these 312,000 shares by the prior Blencathia owner, we did not consider these shares as issued or outstanding for purposes of computing earnings per share prior to 2006. In 2006, we learned that the prior Blencathia owner had, in fact, sold the 312,000 shares for aggregate proceeds of approximately $150,000, without our consent. Accordingly, in the fourth quarter of 2006, we recorded $500,000 of general expenses (representing the cost of the 1999 merger) and the deemed issuance of approximately $150,000 of common stock. The remaining $350,000 obligation was reflected as a current accrued expense. Beginning in 2006, the 312,000 shares have been reflected as outstanding for earnings per share computations. During 2009 and 2010, we made payments totaling $160,000 to the prior Blencathia owner. We did not make any payments to the prior Blencathia owner during 2011, 2012, 2013, 2014 or 2015. The related current accrued expense balance remains at $190,000 at the end of 2015. We are in negotiations with the prior Blencathia owner to resolve this obligation and may ultimately settle the obligation with either cash or equity securities with a lower market value. During 2015, we did not sell any shares to accredited investors. However, we issued 2,075,000 restricted common shares of our stock related to a 2015 note issuance (the "2015 Affiliate Shares"). See Note 7. Notes payable to our financial statements. The 2015 Affiliate Shares were contributed from existing shareholdings of related party Board members and did not increase the total number of our common shares outstanding. During 2014, we sold an aggregate total of 31,978,094 shares to accredited investors which yielded aggregate proceeds of $836,055. On April 12, 2013, our Board authorized and approved the extension of expiration date and change of exercise price for 2,000,000 investor warrants granted to a warrant holder for the purchase of the Company's common stock. The outstanding share purchase warrants originally had a March 23, 2014 expiration date and an exercise price of $0.25. Now the warrant shall expire on April 11, 2018 with an exercise price of $0.25. We analyzed the modification under ASC 718 and ASC 505 and determined no gain or loss is recognized upon the modification due to the warrant having been issued to an investor and investor awards are not subject to either ASC 718 or ASC 505. During 2015, we issued 4,150,000 investor warrants pursuant to a note financing and an additional 296,000 warrants for the placement agent that secured the note financing. See Note 7. Notes Payable. During 2015, we also issued 11,147 investor warrants pursuant to certain prior investor warrant issuances that are subject to dilutive adjustments for share issuances (full ratchet reset features) tied to future issuances of our equity securities. During 2014, we issued 6,666,667 investor warrants pursuant to a convertible note financing and an additional 800,000 warrants for the placement agent that secured the convertible note financing. See Note 6. Convertible Notes Payable. During 2014, we also issued 1,418,987 investor warrants pursuant to certain prior investor warrant issuances that are subject to dilutive adjustments for share issuances (full ratchet reset features) tied to future issuances of our equity securities. No shares were issued to Directors for Director-related services in 2015. During 2014, 1,000,000 restricted shares were issued to a Director for services which resulted in $70,000 of non-cash stock-based compensation expense. As of December 31, 2015 and 2014, we have 32,613,551 and 28,156,404 warrants outstanding, respectively. These warrants were issued as part of equity and/or debt funding efforts that occurred in 2009, 2011, 2012, 2013, 2014 and 2015. Year Warrants Issued No. of Warrants Issued Warrant Exercise Price Warrant Expiration Date 2009 2,000,000 $ 0.15 2018 2011 2,570,750 $ 0.25 2016 2012 9,825,000 $ 0.10 2017 2013 4,875,000 $ 0.10 2018 2014 7,466,667 $ 0.12 2019 2014 1,418,987 $ 0.15 2018 2015 4,446,000 $ 0.12 2020 2015 11,147 $ 0.15 2020 No warrants were exercised during 2015 or 2014. Further information relating to warrants is as follows: Number of Shares Weighted Average Exercise Price Weighted Average Remaining Life (In Years) Outstanding at December 31, 2013 21,595,750 $ 0.15 3.35 Granted 8,885,654 $ 0.12 4.42 Expired (2,325,000 ) $ 0.25 - Outstanding at December 31, 2014 28,156,404 $ 0.12 3.26 Granted 4,457,147 $ 0.12 4.67 Outstanding at December 31, 2015 32,613,551 $ 0.12 2.59 The intrinsic value (difference between the warrant exercise price and our stock share price) attributable to warrants issued was $0 at both December 31, 2015 and 2014.

Stock Options

Stock Options	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Note 4. Stock Options	Long Term Incentive Plan On October 23, 2001, the Board adopted our Long Term Incentive Plan ("LTIP"). The Board is responsible for the administration of this LTIP, and is the approval authority for all option grant awards under this plan. Subject to the express provisions of the LTIP, the Board shall have full authority and sole and absolute discretion to interpret and amend this LTIP, to prescribe, amend and rescind rules and regulations relating to it, and to make all other determinations which it believes to be necessary or advisable in administering this LTIP. On October 22, 2006, our Board adopted the Amended and Restated LTIP. This plan expires on October 21, 2016. The maximum number of shares of common stock as to which awards may be granted under this plan, subject to subsequent amendments, is 18,200,000 shares (updated to reflect the 4% dividend issued during the first quarter of 2009). The common stock issued upon exercise of options or on grant of stock awards may be shares previously authorized but not yet issued or shares which have been issued and reacquired by the Company as treasury stock. The Board may increase the maximum number of shares of common stock as to which awards may be granted at such time as it deems advisable. The following tables summarize information about stock options issued to employees and Directors during the 2 years ended December 31, 2015: Shares Exercise price per share Weighted-average exercise price Aggregate intrinsic value Outstanding at December 31, 2013 9,489,120 $0.09-0.50 $ 0.41 - Granted 30,276,000 $0.05-0.15 $ 0.10 - Cancelled (7,070,400 ) $0.09-0.50 $ 0.39 - Expired (2,220,000 ) $0.18-0.48 $ 0.46 - Outstanding at December 31, 2014 30,474,720 $0.05-0.50 $ 0.10 $ 404,337 Expired (168,720 ) $0.10-0.50 $ 0.37 Outstanding at December 31, 2015 30,306,000 $0.05-0.17 $ 0.10 $ - Options exercisable at December 31, 2015 29,639,333 $0.05-0.17 $ 0.10 Options exercisable at December 31, 2014 27,641,386 $0.05-0.50 $ 0.10 The following table summarizes information about employee stock options outstanding at December 31, 2015: Options outstanding Options exercisable Exercise price range Number outstanding at December 31, 2015 Weighted-average remaining contractual life (years) Weighted-average exercise price Number exercisable at December 31, 2015 Weighted-average exercise price $0.05 - $0.10 15,286,000 3 $ 0.05 14,619,333 $ 0.05 $0.11 - $0.17 15,020,000 3 $ 0.15 15,020,000 $ 0.15 30,306,000 3 $ 0.10 29,639,333 $ 0.10 The following table summarizes information about employee stock options outstanding at December 31, 2014: Options outstanding Options exercisable Exercise price range Number outstanding at December 31, 2014 Weighted-average remaining contractual life (years) Weighted-average exercise price Number exercisable at December 31, 2014 Weighted-average exercise price $0.05 - $0.25 30,348,880 4 $ 0.10 27,515,546 $ 0.10 $0.26 - $0.50 125,840 1 $ 0.44 125,840 $ 0.44 30,474,720 4 $ 0.10 27,641,386 $ 0.10 The following table summarizes information about stock options issued to non-employees during the 2 years ended December 31, 2015: Shares Exercise price per share Weighted-average exercise price Aggregate intrinsic value Outstanding at December 31, 2013 4,137,599 $0.25-0.50 $ 0.46 - Granted 5,730,000 $0.05-0.25 $ 0.18 - Cancelled (1,907,000 ) $0.10-0.48 $ 0.37 - Expired (2,535,599 ) $0.25-0.50 - - Outstanding at December 31, 2014 5,425,000 $0.05-0.25 $ 0.19 $ 8,700 Outstanding at December 31, 2015 5,425,000 $0.05-0.25 $ 0.19 $ - Options exercisable at December 31, 2015 5,425,000 $0.05-0.25 $ 0.19 Options exercisable at December 31, 2014 5,425,000 $0.05-0.25 $ 0.19 Stock option expense recorded in 2015 and 2014 is as follows: Year Ended December 31, 2015 Year Ended December 31, 2014 Awards to employees/Directors $ 148,767 $ 2,492,541 Awards to non-employees - 428,550 Total stock option expense $ 148,767 $ 2,921,091 Employee and Director Awards We did not grant any stock options to employees or Directors for Director-related services during 2015. 168,720 fully vested options previously granted to employees and Directors (in their capacity as Directors) expired during 2015. During 2014, we issued 22,651,200 options to employees and 7,624,800 options to Directors for Director-related services. These option grants were issued in conjunction with the cancellation of 7,070,400 options that had previously been issued to employees and Directors. We calculated the fair value of the to-be cancelled options on the cancellation date and netted the fair value against the fair value of the new grant options. The cancellation of these options resulted in $36,446 of stock option expense reversal. In addition, 2,220,000 fully vested options previously granted to employees and Directors (in their capacity as Directors) expired during 2014. The following table provides the primary assumptions used to value employee and Director non-cash stock-based compensation for the years indicated: Year Ended December 31, 2015 Year Ended December 31, 2014 Weighted-average fair value of options granted NA $ 0.09 Weighted-average assumptions: Risk-free interest rate NA 0.67 Dividend yield NA - Expected volatility NA 1.92 Expected option life (years) NA 5 As of December 31, 2015, there was $903 of total unrecognized compensation cost related to outstanding options granted to employees and Directors. As of December 31, 2014, there was $149,671 of total unrecognized compensation cost related to outstanding options granted to employees and Directors. Non-employee awards We did not grant any stock options to non-employees during 2015. During 2014, we granted 5,730,000 stock options to non-employees. During 2014, we also cancelled 1,907,000 stock options previously granted to non-employees, resulting in $3,653 of stock option expense reversal. 2,535,599 fully vested options previously granted to non-employees expired in 2014. We did not receive proceeds for stock options exercised during 2015 or 2014, as no options were exercised. Services performed by non-employees who were granted options include product/distribution consulting, technology consulting, investor relations and legal services. The weighted-average fair value for such options that have had a fair value calculation applied (NA for 2015 and $0.08 for 2014) was estimated at the date of grant using a Black-Scholes option pricing model. The following weighted-average assumptions were used for the 2014 grants: risk-free interest rate of 0.43%, volatility factor of 2.13, and a weighted-average expected life of the option of approximately 4.40 years. The weighted-average remaining contractual term (in years) of the non-employee options outstanding at December 31, 2015 and 2014 is 1.57 and 2.57, respectively. The aggregate intrinsic value (defined as the excess of the market price of our common stock as of the end of the period over the exercise price of the related stock options) for all stock options (employee, Director and non-employee) outstanding and exercisable as of December 31, 2015 and 2014 was $0 and $413,037 for the respective periods.

Equity Commitment and Related P

Equity Commitment and Related Party Transactions	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Note 5 - Equity Commitment and Related Party Transactions	On August 21, 2015, the Company issued $25,000 of notes payable to Jonathan Burst, our Board chairman and Chief Executive Officer, $10,000 to Michael Gianino, a Director on our Board and $10,000 to Stuart D. Beath, our Chief Financial Officer. These loans were pursuant to the notes payable transaction discussed in Note 7. Notes Payable below. Total cash proceeds from the $45,000 of related party notes payable is $10,000, while the remaining $35,000 is offset with accrued compensation. On August 22, 2014, the Company issued $50,000 of notes payable to Jonathan Burst, our Board chairman and Chief Executive Officer. This loan was pursuant to the convertible note payable transaction discussed in Note 6. Convertible Notes Payable below. Effective December 11, 2007, we received an investment commitment from Rex Carr, a Director of the Company and a holder of over 5% of our common stock. Pursuant to the terms of the commitment, Mr. Rex Carr agreed to invest up to an aggregate of $1,000,000 in the Company, at such time or times as we may request, in the form of a purchase or purchases of our restricted common stock. We may elect to draw from the commitment at one time or from time to time; provided, however, that the aggregate of such draws may not exceed $1,000,000. We have drawn down $500,000 of the commitment and issued to Mr. Rex Carr that number of our shares of restricted common stock equal to the value of the investment then provided to us. The number of shares to be issued was calculated based on the closing price of our common stock as quoted on OTC Market Group's OTCQB marketplace on the date of the sale. There is no stipulation regarding the duration of this commitment.The total amount available under this commitment is $500,000 as of December 31, 2015. Rex Carr passed away on April 27, 2015. On April 30, 2015, the Company elected Glenn Carr to its Board. Glenn Carr is the son of Rex Carr, a deceased Director of the Company. The Company believes that the equity commitment of Rex Carr referenced above will be honored by his estate. However, we can make no assurances as to the timing of when the estate may be settled, and how much we may receive once the estate is settled. As of December 31, 2013, the Company owed $500,000 to Mr. Rex Carr. The terms of the loans associated with this cumulative loan balance did not require the payment of interest and did not require repayment of the principal by a certain date. On February 6, 2014, we issued 10,000,000 restricted shares of Company common stock in exchange for the cancellation of this note payable from a related party in the aggregate (face amount) of $500,000. The fair value of the shares issued based on the February 6, 2014 closing price of our stock ($0.075) was $750,000. This conversion of notes payable from a related party to restricted shares of our common stock was treated separately from the equity commitment in place with Mr. Rex Carr. On February 4, 2013, David B. Norris, a Director of the Company, loaned us $50,000. The terms of this loan did not require the payment of interest and did not require repayment of the principal by a certain date. This loan was converted to 2,500,000 shares of the Company's common stock on February 6, 2014. The fair value of the shares issued based on the February 6, 2014 closing price of our stock ($0.075) was $187,500. In conjunction with the conversion of Mr. Rex Carr's and Mr. Norris' notes payable from a related party to equity, we recorded a $387,500 loss on the conversion of related party notes to our income statement during the twelve months ended December 31, 2014.

Convertible Notes Payable

Convertible Notes Payable	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Note 6 - Convertible Notes Payable	On August 22, 2014 (the "2014 Closing Date"), we closed a financing transaction by entering into a Securities Purchase Agreement dated August 22, 2014 (the "2014 Securities Purchase Agreement") with certain funds and investors signatory to such 2014 Securities Purchase Agreement (the "2014 Purchasers") for an aggregate subscription amount of $1,000,000 (the "2014 Purchase Price") of which $50,000 is from a related party. Pursuant to the 2014 Securities Purchase Agreement, we issued the following to the 2014 Purchasers: (i) 10% Convertible Promissory Notes with an aggregate principal amount of $1,150,000 (the "2014 Notes"), and (ii) warrants to purchase an aggregate of 6,666,667 shares of the Company's common stock, par value $0.01 per share, for an exercise price of $0.12 per share for a period of five (5) years from the effective date of the registration statement (the "2014 Warrants"). We recorded $150,000 of original issuance cost related to this transaction, which we have recorded as debt discount. The terms of the 2014 Notes and the 2014 Warrants are as follows: 10% Convertible Promissory Notes The total principal amount of the 2014 Notes is issued with a 115% premium to the subscription amount. The 2014 Notes accrue interest at a rate equal to 10% per annum and have a maturity date of February 22, 2016. Subsequent to December 31, 2015, the maturity date of the 2014 Notes was extended to April 30, 2016 (see Note 15. Subsequent Events to our financial statements). The 2014 Notes are convertible any time after the issuance date of the 2014 Notes. The 2014 Purchasers have the right to convert the 2014 Notes into shares of the Company's common stock at a conversion price equal to $0.10 per share, subject to standard adjustments for stock dividends, stock splits, subsequent equity sales, subsequent rights offerings and pro rata distributions. While the 2014 Notes are outstanding, in the event of a subsequent equity sale at a price lower than the conversion price of $0.10 per share, the conversion price of the 2014 Notes shall be reduced to the lower conversion price. The 2014 Notes can be redeemed under certain conditions and the Company can force the conversion of the 2014 Notes in the event certain equity conditions are met. In the event of default, the 2014 Purchasers have the right to require the Company to repay in cash all or a portion of the 2014 Notes at a price equal to 125% of the aggregate principal amount of the 2014 Notes plus all accrued but unpaid interest. We recorded $125,347 and $42,018 of interest expense related to the issuance of the 2014 Notes during the twelve months ended December 31, 2015 and 2014, respectively. Warrants The 2014 Warrants are exercisable in whole or in part, at an initial exercise price per share of $0.12, subject to adjustment. The exercise price and number of shares of the Company's common stock issuable under the 2014 Warrants (the "2014 Warrant Shares") are subject to adjustments for stock dividends, splits, combinations, subsequent rights offerings, pro rata distributions and any issuance of securities below the exercise price of the 2014 Warrants. While the 2014 Warrants are outstanding, in the event of a subsequent equity sale including a warrant exercise price lower than the exercise price of $0.12 per share, the exercise price of the 2014 Warrants shall be reduced to the lower exercise price. Any adjustment to the exercise price shall similarly cause the number of 2014 Warrant Shares to be adjusted so that the total value of the 2014 Warrants may increase, provided, that in no event shall the number of 2014 Warrant Shares exceed 200% of the original number of 2014 Warrant Shares originally issued. In addition to the 2014 Warrants described above, the Company also issued 800,000 warrants to a placement agent assisting with the convertible note transaction. The terms of the placement agent warrants are the same as of the terms of the 2014 Warrants explained above. Registration Rights Agreement In connection with the sale of the 2014 Notes and 2014 Warrants pursuant to the 2014 Securities Purchase Agreement, the Company entered into a registration rights agreement (the "2014 Registration Rights Agreement") with the 2014 Purchasers, pursuant to which the Company agreed to register all of the shares of common stock underlying the 2014 Notes and the shares of common stock underlying the 2014 Warrants (together, the "2014 Registrable Securities") on a Form S-1 registration statement (the "2014 Registration Statement") to be filed with the SEC within thirty (30) calendar days following the 2014 Closing Date (the "2014 Filing Deadline") and to use its best efforts to cause the 2014 Registration Statement to be declared effective under the Securities Act within one hundred (100) calendar days following the 2014 Closing Date (the "2014 Effectiveness Deadline"). The 2014 Registration Statement became effective November 26, 2014. Deferred Financing Cost In connection with the convertible note transaction explained above, the Company paid $55,000 for legal fees and $80,000 for placement agent fees. In addition, $29,550 was also recorded to deferred financing costs related to the fair value valuation of the placement agent warrants. $110,547 and $36,995 of deferred financing costs was amortized during the twelve months ended December 31, 2015 and 2014, respectively. The deferred financing cost balance related to the 2014 Notes is $17,008 and $127,555 as of December 31, 2015 and December 31, 2014, respectively. Derivative Because the above convertible 2014 Notes and 2014 Warrants have full reset adjustments tied to future issuances of equity securities by the Company, they are subject to derivative liability treatment under ASC 815-40-15, "Determining Whether an Instrument (or Embedded Feature) is Indexed to an Entity's Own Stock" Debt Discount On issuance date, the fair value of the derivative liability for both the convertible 2014 Notes and 2014 Warrants was $295,773 and $246,905, respectively. Therefore a total of $692,678 (including $150,000 original issuance costs) of debt discount was recorded. $458,172 and $112,704 was recorded as amortization of debt discount during the twelve months ended December 31, 2015 and 2014, respectively. As of December 31, 2015, the convertible 2014 Notes have a balance of $999,697, net of $92,803 of debt discount, and accrued interest of $158,997. As of December 31, 2014, the convertible 2014 Notes have a balance of $541,525, net of $550,975 of debt discount, and accrued interest of $39,917. As of December 31, 2015, the related party convertible 2014 Note has a balance of $52,615, net of $4,885 of debt discount, and accrued interest of $8,368. As of December 31, 2014, the related party convertible 2014 Note has a balance of $28,501, net of $28,999 of debt discount, and accrued interest of $2,101.

Notes Payable

Notes Payable	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Note 7 - Notes Payable	On August 21, 2015 (the "2015 Closing Date"), we closed a financing transaction by entering into a Securities Purchase Agreement dated August 21, 2015 (the "2015 Securities Purchase Agreement") with certain funds and investors signatory to such 2015 Securities Purchase Agreement (the "2015 Purchasers") for an aggregate subscription amount of $415,000 (the "2015 Purchase Price") of which $45,000 is from related parties (see Note 5. Equity Commitment and Related Party Transactions). Pursuant to the 2015 Securities Purchase Agreement, we issued the following to the 2015 Purchasers: (i) 10% Promissory Notes with an aggregate principal amount of $415,000 (the "2015 Notes"), and (ii) warrants to purchase an aggregate of 4,150,000 sharesof the Company's common stock, par value $0.01 per share, for an exercise price of $0.12 per share for a period of five (5) years from the Securities Purchase Agreement date (the "2015 Warrants"). The 2015 Notes are subordinated to the 2014 Notes. In addition, we issued 2,075,000 restricted common shares of our stock to the 2015 Purchasers, previously defined above as the 2015 Affiliate Shares. The 2015 Affiliate Shares have a fair value of $63,787 and were valued based on the closing price of our common stock on August 21, 2015. The 2015 Affiliate Shares were contributed from existing shareholdings of related party Board members and did not increase the total number of our common shares outstanding. The terms of the 2015 Notes and the 2015 Warrants are as follows: 10% Promissory Notes The total principal amount of the 2015 Notes is $415,000. The 2015 Notes accrue interest at a rate equal to 10% per annum and have a maturity date of August 21, 2017. The 2015 Notes can be redeemed by the Company at any time without penalty. In the event of default, the 2015 Purchasers have the right to require the Company to repay in cash all or a portion of the 2015 Notes at a price equal to 125% of the aggregate principal amount of the 2015 Notes plus all accrued but unpaid interest. We recorded $14,440 and $0 of interest expense related to the issuance of the 2015 Notes during the twelve months ended December 31, 2015 and 2014, respectively. Warrants The 2015 Warrants are exercisable in whole or in part, at an initial exercise price per share of $0.12, subject to adjustment. The exercise price and number of shares of the Company's common stock issuable under the 2015 Warrants (the "2015 Warrant Shares") are subject to adjustments for stock dividends, splits, combinations, subsequent rights offerings, pro rata distributions and any issuance of securities below the exercise price of the 2015 Warrants. While the 2015 Warrants are outstanding, in the event of a subsequent equity sale including a warrant exercise price lower than the exercise price of $0.12 per share, the exercise price of the 2015 Warrants shall be reduced to the lower exercise price. Any adjustment to the exercise price shall similarly cause the number of 2015 Warrant Shares to be adjusted so that the total value of the 2015 Warrants may increase. In addition to the 2015 Warrants described above, the Company also issued 296,000 warrants to a placement agent assisting with the 2015 Notes transaction. The terms of the placement agent warrants are the same as of the terms of the 2015 Warrants explained above. Deferred Financing Cost In connection with the note transaction explained above, the Company paid $7,500 for legal fees and $29,600 for placement agent fees. In addition, $12,775 was also recorded to deferred financing costs related to the fair value valuation of the placement agent warrants. $9,006 and $0 of deferred financing costs was amortized during the twelve months ended December 31, 2015 and 2014, respectively. The deferred financing cost balance related to the 2015 Notes is $40,869 and $0 as of December 31, 2015 and December 31, 2014, respectively. Derivative Because the above 2015 Notes and 2015 Warrants have full reset adjustments tied to future issuances of equity securities by the Company, they are subject to derivative liability treatment under ASC 815-40-15. ASC 815-40-15 requires as of the date the 2015 Notes and 2015 Warrants are issued, the derivative liability to be measured at the fair value and re-evaluated at the end of each reporting period. See Note 8. Derivative Liability. Debt Discount On issuance date, the fair value of the derivative liability for the 2015 Warrants was $179,106. Also, the relative fair value of the 2015 Affiliate Shares was $63,787. Therefore a total of $242,893 of debt discount was recorded. $51,826 and $0 was recorded as amortization of debt discount during the twelve months ended December 31, 2015 and 2014, respectively. As of December 31, 2015, the 2015 Notes have a balance of $194,177, net of $175,823 of debt discount, and accrued interest of $12,874. As of December 31, 2015, the related party 2015 Notes have a balance of $29,757, net of $15,243 of debt discount, and accrued interest of $1,565.

Derivative Liability

Derivative Liability	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Note 8 - Derivative Liability	During 2009, we granted a warrant to purchase 2,000,000 shares of the Company's common stock to an accredited investor in conjunction with equity raise efforts. On April 12, 2013, our Board authorized and approved the extension of the expiration date and a change of exercise price for this warrant. The outstanding share purchase warrant originally had a March 23, 2014 expiration date and an exercise price of $0.25. The new modified terms extended the warrant expiration date to April 11, 2018 and reduced the exercise price to $0.226. The exercise price is also subject to dilutive adjustments for share issuances (full ratchet reset features). As of December 31, 2015 and December 31, 2014, the exercise price has been reduced to approximately $0.15 and an additional 1,430,134 (as of September 30, 2015) and 1,418,987 (as of December 31, 2014) warrants, respectively, are to be issued to the investor due to the reset features. On August 21, 2015, we issued 4,150,000 warrants to investors and 296,000 warrants to a placement agent. The exercise price of these warrants is also subject to dilutive adjustments for share issuance (full ratchet reset features). See Note 7. Notes Payable. On August 22, 2014, we issued 6,666,667 warrants to investors and 800,000 warrants to a placement agent. The exercise price of these warrants is also subject to dilutive adjustments for share issuance (full ratchet reset features). See Note 6. Convertible Notes Payable. Because the convertible 2014 Notes, 2014 Warrants and 2015 Warrants all have full reset adjustments tied to future issuances of equity securities by the Company, they are subject to derivative liability treatment under ASC 815-40-15, which requires as of the date the convertible 2014 Notes, 2014 Warrants and 2015 Warrants are issued, the derivative liability to be measured at fair value and re-evaluated at the end of each reporting period. Key assumptions used to determine the fair value of the convertible 2014 Notes are as follows: Stock price volatility (one-year measurement): December 31, 2014 measurement 192 % December 31, 2015 measurement 174 % Probability of default triggering 21% interest rate, increasing 1% per month to a maximum of 10% with a 125% penalty 0 % Probability of the Company redeeming the convertible 2014 Notes (with 130% penalty): projected initially at 0% of the time, increasing 1% monthly to a maximum of 5% (from alternative financing being available for a redemption event to occur) Conversion behavior - holder automatically converts the convertible 2014 Notes at a maximum of 2 times the conversion price. Key assumptions used to determine the fair value of the 2014 Warrants and 2015 Warrants are as follows Stock price volatility (one-year measurement): December 31, 2014 measurement 192 % August 21, 2015 measurement 158 % December 31, 2015 measurement 174 % Exercise behavior – warrant exercise at target prices 2 times the higher of the projected reset price or stock price. As of December 31, 2015, the fair value of the total convertible 2014 Notes, 2014 Warrants and 2015 Warrants' derivative liability is $425,035 and we recognized a gain on derivative liability of $224,226 and $114,848 for the twelve months ended December 31, 2015 and 2014, respectively. As of December 31, 2014, the fair value of the total convertible 2014 Notes and 2014 Warrants' derivative liability is $457,380. The following table summarizes the derivative liability included in the balance sheet: Balance at December 31, 2013 $ - Debt discount due to 2014 Notes $ 295,773 Debt discount due to warrants issued with 2014 Notes $ 246,905 Deferred financing cost due to derivative liability for placement agent warrant $ 29,550 Gain on change of fair value $ (114,848 ) Balance at December 31, 2014 $ 457,380 Debt discount due to warrants issued with 2015 Notes $ 179,106 Deferred financing cost originated from derivative liability $ 12,775 Gain on change of fair value $ (224,226 ) Balance at December 31, 2015 $ 425,035 The following table summarizes information about warrants outstanding as of December 31, 2015: Total # of warrants issued and outstanding 32,613,551 Weighted-average exercise price $ 0.12 Remaining life (in years) 2.59 Intrinsic value $ -

Deferred Revenue

Deferred Revenue	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Note 9. Deferred Revenue	On February 26, 2009, we received the first purchase order pursuant to a Memorandum of Understanding ("MOU") with Libya Oil Holdings Limited, Tamoil, Libya Africa Investment Portfolio ad Vision Oil Services Ltd ("VOS"). Pursuant to the MOU, VOS paid for the purchase of 600 metric tons of DiesoLiFT TM Based upon a written legal opinion received during the first quarter of 2014, it was determined that effective February 2014, we were no longer obligated to present the nearly $3 million deferred revenue liability on our balance sheet as the statute of limitations period for our performance obligation has passed. In conjunction with this determination, we recorded a gain on deferred revenue liability write off of approximately $3 million during the twelve months ended December 31, 2014.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Note 10. Income Taxes	We use the liability method, where deferred tax assets and liabilities are determined based on the expected future tax consequences of temporary differences between the carrying amounts of assets and liabilities for financial and income tax reporting purposes. We have historically incurred losses from operations and therefore had no tax liability. The net deferred asset generated by the NOL carry-forward has been fully reserved. The cumulative NOL carry-forward is approximately $50.1 million and $47.9 million as of December 31, 2015 and 2014, respectively, and will begin expiring in 2017. Deferred tax assets consist of the tax effect of NOL carry-forwards. We have provided a full valuation allowance on the deferred tax assets because of the uncertainty regarding their realizability. However, because goodwill is not depreciated and has an indefinite life for book purposes, the deferred tax liability related to the book to tax basis difference is not offset against the deferred tax assets when establishing our valuation allowance. Deferred tax assets consist of the following: Year ended December 31, 2015 2014 Deferred tax asset $ 20,138,621 $ 19,161,984 Valuation allowance (20,138,621 ) (19,161,984 ) Deferred tax liability $ 723,000 $ 723,000

Lease Commitments

Lease Commitments	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Note 11. Lease Commitments	We entered into an operating lease for office space on January 1, 2002 that, as extended, now expires on April 30, 2017. Rent expense was $44,706 and $43,937 during the fiscal years ended December 31, 2015 and 2014, respectively. We entered into a new 5-year office equipment lease in July 2014. Future minimum lease payments as of December 31, 2015 are displayed below: Year ending December 31, 2016 $ 49,874 2017 $ 17,918 2018 $ 1,764 2019 $ 882 2020 $ - Total minimum lease payments $ 70,438

Accounts Payable

Accounts Payable	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Note 12. Accounts Payable	As of December 31, 2014, we recognized a $59,899 gain on write off of accounts payable. The invoice and contracts for the total of $59,899 were dated at least five years before December 31, 2014. Based on a written legal opinion received during the third quarter of 2014, it was determined that effective September 30, 2014, we were no longer obligated to present the $59,899 of accounts payable on our balance sheet as the statute of limitation period for our payment obligation has passed. In conjunction with this determination, we recorded a gain on accounts payable write off of $59,899 during the twelve months ended December 31, 2014.

Inventory Write Off

Inventory Write Off	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Note 13. Inventory Write Off	During the twelve months ended December 31, 2015, we recognized a $44,518 loss on write off of inventory primarily residing in the United States. As the inventory is not obsolete, we will record a gain on write off of inventory in the event that such inventory is subsequently sold.

Legal Proceedings

Legal Proceedings	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Note 14 - Legal Proceedings	We are periodically subject to various lawsuits and claims with respect to matters arising out of the normal course of business. While the impact on future financial results is not subject to reasonable estimation because considerable uncertainty exists, management believes, after consulting with counsel, that it is more likely than not that the ultimate liabilities resulting from such lawsuits and claims will not materially affect our financial position, results of operations or liquidity. On July 31, 2006, we received notice from the American Arbitration Association ("AAA") of a Demand for Arbitration dated July 27, 2006 received by the AAA naming the Company as Respondent and TPG Capital Partners ("TPG"), the prior Blencathia owner, as the Claimant. The arbitration had been requested by TPG to resolve an alleged aggregate proceeds shortfall from the sale of our securities issued in the Blencathia merger. TPG has claimed they sold some or all of the 312,000 shares and the sales have not generated at least $500,000 of proceeds, as guaranteed in the merger documents. In an effort to resolve this matter prior to submission to binding arbitration, both TPG and the Company participated in a non-binding mediation conference on January 30, 2007, which did not resolve the matter. Informal discussions are ongoing. It is not expected that the ultimate settlement of this matter, considering we have recorded a liability for the shortfall amount, will have an additional adverse material effect on the Company. Since 2009, the Company has made payments to TPG totaling $160,000 to reduce the recorded liability. The remaining recorded liability balance is $190,000 at December 31, 2015 and 2014, respectively. We are a defendant in litigation with a former employee regarding accrued but unpaid salary. We are in discussions for settlement of this claim and have accrued an amount that we believe will resolve this matter.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Note 15. Subsequent Events	Subsequent to December 31, 2015, we received a cumulative total of $373,750 in the form of subordinated notes; $273,750 from external investors and $100,000 from two Directors of the Company (the "2016 Interim Financing"). The 2016 Interim Financing notes include the issuance of ten (10) warrants to purchase shares of our common stock for every United States dollar invested. The 2016 Interim Financing notes' warrants have an exercise price of $0.05 and mature five years from the issuance date. The 2016 Interim Financing notes provide for a return of principal with a 1.5 factor, with a maturity date of April 30, 2016, or sooner depending on whether the Company is able to secure long term capital prior to April 30, 2016. If the 2016 Interim Financing notes are not repaid by April 30, 2016, they will begin accruing simple interest at an annual rate of 10% on a principal amount calculated by taking the original investment amount multiplied by the 1.5 factor. As a result of the 2016 Interim Funding, and pursuant to a binding memorandum of understanding between the Company and all of the 2014 Note holders, the maturity date of the 2014 Notes was extended from February 22, 2016 to April 30, 2016. On March 25, 2016, we filed a certificate of amendment to our Articles of Incorporation increasing the number of our authorized shares from 350,000,000 to 750,000,000 shares with the Nevada Secretary of State.

Nature of Business and Signif22

Nature of Business and Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2015
Nature Of Business And Significant Accounting Policies Policies
Use of Estimates in the Preparation of Financial Statements	The preparation of financial statements in conformity with United States generally accepted accounting principles ("GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Concentration of Credit Risk	Financial instruments which potentially subject the Company to concentrations of credit risk consist of cash and trade receivables. We place our cash with high credit quality financial institutions. At times such cash may be in excess of the Federal Deposit Insurance Corporation ("FDIC") limit. With respect to trade receivables, we routinely assess the financial strength of our customers and, as a consequence, believe that our receivable credit risk exposure is limited.
Related Parties	A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests is also a related party.
Revenue Recognition	We recognize revenue from the sale of our products when the price is fixed and determinable, persuasive evidence of an arrangement exists, the products are shipped, and title and risk of loss has passed to the buyer and collectability of the resulting receivable is reasonably assured. A majority of our revenues is from sales to product distributors. Product distributors do not have the option to return product that is not immediately sold to an end-user. Therefore, our revenue recognition is not conditional on whether a distributor is able to sell product to an ultimate product end-user. Our sales policies for end-users are consistent with product distributor sales policies. Beginning in May 2013, as an effort to address our outstanding payable balance with and at the request of our product manufacturer, our non-United States customers began remitting receivable payments directly to our product manufacturer in lieu of remitting payment directly to us. Under this arrangement, we still maintained the risks and benefits related to sending the product to each customer and thus recorded sales revenues (and associated cost of sales) applying the gross reporting treatment for each transaction pursuant to the Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") ASC 605-45, " Principal Agent Considerations."
Cash and Cash Equivalents	Cash and cash equivalents include cash on hand and temporary investments with a maturity of three months or less. We maintain cash in a bank account, which, at times, exceeds federally insured limits. We have experienced no losses relating to these excess amounts of cash in a bank. We utilize a cash management program that assesses daily cash requirements. Excess funds are invested in overnight repurchase agreements backed by United States Treasury securities. Repurchase agreements are not deposits, are not insured or guaranteed by the United States government, the FDIC or any other government agency, and involve investment risk including possible loss of principal. In addition, during 2014, we established a bank facility that has the functionality to hold cash in various international denominations. As of December 31, 2015, we did not have any cash balances held in international denominations and therefore no marking-to-market was required. As of December 31, 2014, we only had international funds held in euros. The balance of this euro account was marked-to-market as of December 31, 2014.
Accounts Receivable	An allowance for doubtful accounts is maintained at a level we believe sufficient to cover potential losses based on historical trends and known current factors impacting our customers. We have determined that an allowance for doubtful accounts was not necessary as of December 31, 2015 and 2014. We did, however, write off $13,735 and $170,875 of accounts receivable that was expensed in 2015 and 2014, respectively.
Inventory	Inventory, which consists solely of finished product, is valued at the lower of cost or market, based on the first-in, first-out ("FIFO") method, or market, and reflects the purchased cost from vendors. Although we maintain minimal inventory levels in the United States at external storage facilities, the majority of our inventory is manufactured based on customer demand and immediately shipped to customers upon completion. The raw material components required to manufacture our products reside at our product manufacturer's facilities and are not owned by us. During 2015, we wrote off $44,518 of certain inventory, primarily in the United States, which has sat idle for at least a one-year period. In the event that such inventory is subsequently sold to customers, we will record a gain on the recovery of inventory sold to customers. See Note 13. Inventory Write Off to our financial statements.
Goodwill	We account for goodwill and intangible assets in accordance with ASC 350 "Intangibles-Goodwill and Other" We completed an evaluation of goodwill at December 31, 2015 and 2014 and determined that there was no impairment. We employed a qualitative evaluation for the 2015 and 2014 analyses.
Income Taxes	We account for income taxes utilizing ASC 740, "Income Taxes."
Research and Development	Research and development costs are expensed as incurred. Expense for services received from external vendors for 2015 and 2014 was $0 and $24,090, respectively.
Advertising Expenses	Advertising costs are expensed as incurred and amounted to $16,735 and $173,763 in 2015 and 2014, respectively.
Basic and Diluted Net Earnings (Loss) Per Common Share	We account for earnings per share pursuant to ASC 260, " Earnings per Share
Derivative Financial Instruments	We evaluate our financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in our statements of operations. For stock-based derivative financial instruments, we use a Lattice Model option pricing model, in accordance with ASC 815-15, "Derivatives and Hedging,"
Fair Value of Financial Instruments	We measure our financial assets and liabilities in accordance with the requirements of ASC 820, "Fair Value Measurements and Disclosures." Level 1 - Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities. Level 2 - Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars. Level 3 - Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management's best estimate of fair value. The following table sets forth by level within the fair value hierarchy our financial assets and liabilities that were accounted for at fair value as of December 31, 2015, and December 31, 2014: Recurring Fair Value Measures Level 1 Level 2 Level 3 Total December 31, 2015 Derivative liability $ - $ - $ 425,035 $ 425,035 December 31, 2014 Derivative liability $ - $ - $ 457,380 $ 457,380
Employee Stock-Based Compensation	We account for stock-based compensation in accordance with ASC 718, " Compensation-Stock Compensation
Non-Employee Stock-Based Compensation	We account for stock-based compensation in accordance with the provision of ASC 505, "Equity Based Payments to Non-Employees"
Recently Issued Accounting Pronouncements	Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on our financial statements.

Nature of Business and Signif23

Nature of Business and Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2015
Nature Of Business And Significant Accounting Policies Tables
Schedules of Concentration of Revenue	Customers whose revenues exceeded 10% of our total revenues for 2015 and 2014 are listed below: Customer Name 2015 2014 Nordmann, Rassmann 80 % 75 % Unipart Group NA 13 %
Net revenues by foreign country	Net revenues related to shipments into various foreign countries were $417,532 and $1,669,037 during 2015 and 2014, respectively. The following table breaks out net revenues by foreign country: Country 2015 2014 Czech. Republic $ 71,806 $ 127,980 Cyprus - 5,665 France 38,919 29,843 Germany 290,658 1,103,970 Romania - 68,336 United Kingdom 16,149 333,243 $ 417,532 $ 1,669,037
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	The following table sets forth by level within the fair value hierarchy our financial assets and liabilities that were accounted for at fair value as of December 31, 2015, and December 31, 2014: Recurring Fair Value Measures Level 1 Level 2 Level 3 Total December 31, 2015 Derivative liability $ - $ - $ 425,035 $ 425,035 December 31, 2014 Derivative liability $ - $ - $ 457,380 $ 457,380

Stockholders' Equity (Deficit)

Stockholders' Equity (Deficit) (Tables)	12 Months Ended
	Dec. 31, 2015
Stockholders Equity Deficit Tables
Schedule of Warrants Issued	These warrants were issued as part of equity and/or debt funding efforts that occurred in 2009, 2011, 2012, 2013, 2014 and 2015. Year Warrants Issued No. of Warrants Issued Warrant Exercise Price Warrant Expiration Date 2009 2,000,000 $ 0.15 2018 2011 2,570,750 $ 0.25 2016 2012 9,825,000 $ 0.10 2017 2013 4,875,000 $ 0.10 2018 2014 7,466,667 $ 0.12 2019 2014 1,418,987 $ 0.15 2018 2015 4,446,000 $ 0.12 2020 2015 11,147 $ 0.15 2020
Schedule of Information related to Warrants	Further information relating to warrants is as follows: Number of Shares Weighted Average Exercise Price Weighted Average Remaining Life (In Years) Outstanding at December 31, 2013 21,595,750 $ 0.15 3.35 Granted 8,885,654 $ 0.12 4.42 Expired (2,325,000 ) $ 0.25 - Outstanding at December 31, 2014 28,156,404 $ 0.12 3.26 Granted 4,457,147 $ 0.12 4.67 Outstanding at December 31, 2015 32,613,551 $ 0.12 2.59

Stock Options (Tables)

Stock Options (Tables)	12 Months Ended
	Dec. 31, 2015
Stock Options Tables
Schedule of Stock Option Issued to Employees and Directors	The following tables summarize information about stock options issued to employees and Directors during the 2 years ended December 31, 2015: Shares Exercise price per share Weighted-average exercise price Aggregate intrinsic value Outstanding at December 31, 2013 9,489,120 $0.09-0.50 $ 0.41 - Granted 30,276,000 $0.05-0.15 $ 0.10 - Cancelled (7,070,400 ) $0.09-0.50 $ 0.39 - Expired (2,220,000 ) $0.18-0.48 $ 0.46 - Outstanding at December 31, 2014 30,474,720 $0.05-0.50 $ 0.10 $ 404,337 Expired (168,720 ) $0.10-0.50 $ 0.37 Outstanding at December 31, 2015 30,306,000 $0.05-0.17 $ 0.10 $ - Options exercisable at December 31, 2015 29,639,333 $0.05-0.17 $ 0.10 Options exercisable at December 31, 2014 27,641,386 $0.05-0.50 $ 0.10
Schedule of Employee Stock Option Outstanding	The following table summarizes information about employee stock options outstanding at December 31, 2015: Options outstanding Options exercisable Exercise price range Number outstanding at December 31, 2015 Weighted-average remaining contractual life (years) Weighted-average exercise price Number exercisable at December 31, 2015 Weighted-average exercise price $0.05 - $0.10 15,286,000 3 $ 0.05 14,619,333 $ 0.05 $0.11 - $0.17 15,020,000 3 $ 0.15 15,020,000 $ 0.15 30,306,000 3 $ 0.10 29,639,333 $ 0.10 The following table summarizes information about employee stock options outstanding at December 31, 2014: Options outstanding Options exercisable Exercise price range Number outstanding at December 31, 2014 Weighted-average remaining contractual life (years) Weighted-average exercise price Number exercisable at December 31, 2014 Weighted-average exercise price $0.05 - $0.25 30,348,880 4 $ 0.10 27,515,546 $ 0.10 $0.26 - $0.50 125,840 1 $ 0.44 125,840 $ 0.44 30,474,720 4 $ 0.10 27,641,386 $ 0.10
Schedule of Stock Option Issued to non employees	The following table summarizes information about stock options issued to non-employees during the 2 years ended December 31, 2015: Shares Exercise price per share Weighted-average exercise price Aggregate intrinsic value Outstanding at December 31, 2013 4,137,599 $0.25-0.50 $ 0.46 - Granted 5,730,000 $0.05-0.25 $ 0.18 - Cancelled (1,907,000 ) $0.10-0.48 $ 0.37 - Expired (2,535,599 ) $0.25-0.50 - - Outstanding at December 31, 2014 5,425,000 $0.05-0.25 $ 0.19 $ 8,700 Outstanding at December 31, 2015 5,425,000 $0.05-0.25 $ 0.19 $ - Options exercisable at December 31, 2015 5,425,000 $0.05-0.25 $ 0.19 Options exercisable at December 31, 2014 5,425,000 $0.05-0.25 $ 0.19
Schedule of Stock Option Recorded	Stock option expense recorded in 2015 and 2014 is as follows: Year Ended December 31, 2015 Year Ended December 31, 2014 Awards to employees/Directors $ 148,767 $ 2,492,541 Awards to non-employees - 428,550 Total stock option expense $ 148,767 $ 2,921,091
Schedule of primary assumptions used to value employee and Director non-cash stock-based compensation	The following table provides the primary assumptions used to value employee and Director non-cash stock-based compensation for the years indicated: Year Ended December 31, 2015 Year Ended December 31, 2014 Weighted-average fair value of options granted NA $ 0.09 Weighted-average assumptions: Risk-free interest rate NA 0.67 Dividend yield NA - Expected volatility NA 1.92 Expected option life (years) NA 5

Derivative Liability (Tables)

Derivative Liability (Tables)	12 Months Ended
	Dec. 31, 2015
Derivative Liability Tables
Fair value of convertible note	Key assumptions used to determine the fair value of the convertible 2014 Notes are as follows: Stock price volatility (one-year measurement): December 31, 2014 measurement 192 % December 31, 2015 measurement 174 % Probability of default triggering 21% interest rate, increasing 1% per month to a maximum of 10% with a 125% penalty 0 % Probability of the Company redeeming the convertible 2014 Notes (with 130% penalty): projected initially at 0% of the time, increasing 1% monthly to a maximum of 5% (from alternative financing being available for a redemption event to occur) Conversion behavior - holder automatically converts the convertible 2014 Notes at a maximum of 2 times the conversion price.
Fair value of the warrants	Key assumptions used to determine the fair value of the 2014 Warrants and 2015 Warrants are as follows: Stock price volatility (one-year measurement): December 31, 2014 measurement 192 % August 21, 2015 measurement 158 % December 31, 2015 measurement 174 % Exercise behavior – warrant exercise at target prices 2 times the higher of the projected reset price or stock price.
Summary of derivative liability	The following table summarizes the derivative liability included in the balance sheet: Balance at December 31, 2013 $ - Debt discount due to 2014 Notes $ 295,773 Debt discount due to warrants issued with 2014 Notes $ 246,905 Deferred financing cost due to derivative liability for placement agent warrant $ 29,550 Gain on change of fair value $ (114,848 ) Balance at December 31, 2014 $ 457,380 Debt discount due to warrants issued with 2015 Notes $ 179,106 Deferred financing cost originated from derivative liability $ 12,775 Gain on change of fair value $ (224,226 ) Balance at December 31, 2015 $ 425,035
Summary of warrants outstanding	The following table summarizes information about warrants outstanding as of December 31, 2015: Total # of warrants issued and outstanding 32,613,551 Weighted-average exercise price $ 0.12 Remaining life (in years) 2.59 Intrinsic value $ -

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2015
Income Taxes Tables
Deferred tax liability	Deferred tax assets consist of the following: Year ended December 31, 2015 2014 Deferred tax asset $ 20,138,621 $ 19,161,984 Valuation allowance (20,138,621 ) (19,161,984 ) Deferred tax liability $ 723,000 $ 723,000

Lease Commitments (Tables)

Lease Commitments (Tables)	12 Months Ended
	Dec. 31, 2015
Lease Commitments Tables
Schedule of Minimum Future Lease Payment	Future minimum lease payments as of December 31, 2015 are displayed below: Year ending December 31, 2016 $ 49,874 2017 $ 17,918 2018 $ 1,764 2019 $ 882 2020 $ - Total minimum lease payments $ 70,438

Nature of Business and Signif29

Nature of Business and Significant Accounting Policies (Details)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Nordmann, Rassmann [Member]
Net revenue in percentage	80.00%	75.00%
Unipart Group [Member]
Net revenue in percentage		13.00%

Nature of Business and Signif30

Nature of Business and Significant Accounting Policies (Details 1) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Net revenues related to shipments	$ 417,532	$ 1,669,037
Czech Republic [Member]
Net revenues related to shipments	$ 71,806	127,980
Cyprus [Member]
Net revenues related to shipments		5,665
France [Member]
Net revenues related to shipments	$ 38,919	29,843
Germany [Member]
Net revenues related to shipments	$ 290,658	1,103,970
Romania [Member]
Net revenues related to shipments		68,336
United Kingdom [Member]
Net revenues related to shipments	$ 16,149	$ 333,243

Nature of Business and Signif31

Nature of Business and Significant Accounting Policies (Details 2) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Derivative liability	$ 425,035	$ 457,380
Level 1 [Member]
Derivative liability
Level 2 [Member]
Derivative liability
Level 3 [Member]
Derivative liability	$ 425,035	$ 457,380

Nature of Business and Signif32

Nature of Business and Significant Accounting Policies (Details Narrative)	12 Months Ended
	Dec. 31, 2015USD ($)Number	Dec. 31, 2014USD ($)Number
Nature Of Business And Significant Accounting Policies Details Narrative
Accounts receivable in percent	100.00%	82.00%
Number of customers | Number	1	4
Net sales revenues	$ 417,532	$ 1,669,037
Production handled by Brenntag	100.00%	100.00%
Accounts receivable write off	$ 13,735	$ 170,875
Loss on inventory write off	$ 44,518
Research and development expense		$ 24,090
Advertising costs	$ 16,735	$ 173,763

Stockholders Equity (Deficit) (

Stockholders Equity (Deficit) (Details)	12 Months Ended
	Dec. 31, 2015$ / sharesshares
2,009
No of warrants issued | shares	2,000,000
Warrant Exercise Price | $ / shares	$ 0.15
Warrant Expiration Date	2,018
2,011
No of warrants issued | shares	2,570,750
Warrant Exercise Price | $ / shares	$ 0.25
Warrant Expiration Date	2,016
2,012
No of warrants issued | shares	9,825,000
Warrant Exercise Price | $ / shares	$ 0.1
Warrant Expiration Date	2,017
2,013
No of warrants issued | shares	4,875,000
Warrant Exercise Price | $ / shares	$ 0.1
Warrant Expiration Date	2,018
2,014
No of warrants issued | shares	7,466,667
Warrant Exercise Price | $ / shares	$ 0.12
Warrant Expiration Date	2,019
2,014
No of warrants issued | shares	1,418,987
Warrant Exercise Price | $ / shares	$ 0.15
Warrant Expiration Date	2,018
2,015
No of warrants issued | shares	4,446,000
Warrant Exercise Price | $ / shares	$ 0.12
Warrant Expiration Date	2,020
2,015
No of warrants issued | shares	11,147
Warrant Exercise Price | $ / shares	$ 0.15
Warrant Expiration Date	2,020

Stockholders Equity (Deficit)34

Stockholders Equity (Deficit) (Details 1) - $ / shares	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Weighted Average Exercise Price
Granted	$ 0.10	$ 0.10
Warrant [Member]
Number of Shares
Outstanding, Beginning	28,156,404	21,595,750
Granted	4,457,147	8,885,654
Expired		(2,325,000)
Outstanding, Ending	32,613,551	28,156,404
Weighted Average Exercise Price
Outstanding, Beginning	$ 0.12	$ 0.15
Granted	0.12	0.12
Expired		0.25
Outstanding, Ending	$ 0.12	$ 0.12
Weighted average remaining life Outstanding at beginning of year	3 years 3 months 4 days	3 years 4 months 6 days
Granted	4 years 8 months 1 day	4 years 5 months 1 day
Weighted average remaining life Outstanding at end of year	2 years 7 months 2 days	3 years 3 months 4 days

Stockholders' Equity (Deficit35

Stockholders' Equity (Deficit) (Details Narrative) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Stockholders Equity Deficit Details Narrative
Warrants outstanding	32,613,551	28,156,404
Intrinsic value of warrants issued	$ 0	$ 0

Stock Options (Details)

Stock Options (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Number of Shares
Exercisable	29,639,333	27,641,386
Weighted Average Exercise Price
Granted	$ 0.10	$ 0.10
Employees and Directors [Member]
Number of Shares
Outstanding, Beginning	30,474,720	9,489,120
Granted		30,276,000
Cancelled		(7,070,400)
Expired	(168,720)	(2,220,000)
Outstanding, Ending	30,306,000	30,474,720
Exercisable	29,639,333	27,641,386
Weighted Average Exercise Price
Outstanding, Beginning	$ 0.10	$ 0.41
Granted		0.10
Cancelled		0.39
Expired	0.37	0.46
Outstanding, Ending	0.10	0.10
Exercisable	0.10	$ 0.01
Aggregate intrinsic value		$ 404,337
Employees and Directors [Member] | Minimum [Member]
Exercise Price Per Share
Exercise price, Beginning	0.05	$ 0.09
Granted		0.05
Cancelled		0.09
Expired	0.10	0.18
Exercise price, Ending	0.05	0.05
Exercisable	0.05	0.05
Employees and Directors [Member] | Maximum [Member]
Exercise Price Per Share
Exercise price, Beginning	0.50	0.50
Granted		0.15
Cancelled		0.50
Expired	0.50	0.48
Exercise price, Ending	0.17	0.50
Exercisable	$ 0.17	$ 0.50

Stock Options (Details 1)

Stock Options (Details 1) - $ / shares	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Options Outstanding at end of year	30,306,000	30,474,720
Weighted average exercise price	$ 0.10	$ 0.10
Exercisable at end of year	29,639,333	27,641,386
Weighted average exercise price of options exercisable at end of year	$ 0.10	$ 0.10
$0.05 - $0.10
Exercise Price Range, Lower Range	0.05
Exercise Price Range, Upper Range	$ 0.10
Options Outstanding at end of year	15,286,000
Weighted-average remaining contractual life (in years)	3 years
Weighted average exercise price	$ 0.05
Exercisable at end of year	14,619,333
Weighted average exercise price of options exercisable at end of year	$ 0.05
$0.11 - $0.17
Exercise Price Range, Lower Range	0.11
Exercise Price Range, Upper Range	$ 0.17
Options Outstanding at end of year	15,020,000
Weighted-average remaining contractual life (in years)	3 years
Weighted average exercise price	$ 0.15
Exercisable at end of year	15,020,000
Weighted average exercise price of options exercisable at end of year	$ 0.15
$0.05 - $0.25
Exercise Price Range, Lower Range		0.05
Exercise Price Range, Upper Range		$ 0.25
Options Outstanding at end of year		30,348,880
Weighted-average remaining contractual life (in years)		4 years
Weighted average exercise price		$ 0.10
Exercisable at end of year		27,515,546
Weighted average exercise price of options exercisable at end of year		$ 0.10
$0.26 - $0.50
Exercise Price Range, Lower Range		0.26
Exercise Price Range, Upper Range		$ 0.50
Options Outstanding at end of year		125,840
Weighted-average remaining contractual life (in years)		1 year
Weighted average exercise price		$ 0.44
Exercisable at end of year		125,840
Weighted average exercise price of options exercisable at end of year		$ 0.44

Stock Options (Details 2)

Stock Options (Details 2) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Number of Shares
Exercisable	29,639,333	27,641,386
Weighted Average Exercise Price
Granted	$ 0.10	$ 0.10
Non-employees
Number of Shares
Outstanding, Beginning	5,425,000	4,137,599
Granted		5,730,000
Cancelled		(1,907,000)
Expired		(2,535,599)
Outstanding, Ending	5,425,000	5,425,000
Exercisable	5,425,000	5,425,000
Weighted Average Exercise Price
Outstanding, Beginning	$ 0.19	$ 0.46
Granted		0.18
Cancelled		$ 0.37
Expired
Outstanding, Ending	0.19	$ 0.19
Exercisable	0.19	$ 0.19
Aggregate intrinsic value		$ 8,700
Non-employees | Minimum [Member]
Exercise Price Per Share
Exercise price, Beginning	0.05	$ 0.25
Granted		0.05
Cancelled		0.10
Expired		0.25
Exercise price, Ending	0.05	0.05
Exercisable	0.05	0.05
Non-employees | Maximum [Member]
Exercise Price Per Share
Exercise price, Beginning	0.25	0.50
Granted		0.25
Cancelled		0.48
Expired		0.50
Exercise price, Ending	0.25	0.25
Exercisable	$ 0.25	$ 0.25

Stock Options (Details 3)

Stock Options (Details 3) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Stock Options Details 3
Awards to employees/Directors	$ 148,767	$ 2,492,541
Awards to non-employees		428,550
Total stock option expense	$ 148,767	$ 2,921,091

Stock Options (Details 4)

Stock Options (Details 4) - $ / shares	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Stock Options Details 3
Weighted-average fair value of options granted		$ 0.09
Weighted-average assumptions:
Risk-free interest rate		$ 0.67
Dividend yield
Expected volatility		1.92%
Expected option life (years)		5 years

Stock Options (Details Narrativ

Stock Options (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Stock Options Details Narrative
Unrecognized compensation	$ 903	$ 149,671
Weighted-average remaining contractual term (in years)	1 year 6 months 26 days	2 years 6 months 26 days
Intrinsic value	$ 0	$ 413,037

Equity Commitment and Related42

Equity Commitment and Related Party Transactions (Details Narrative) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Equity Commitment And Related Party Transactions Details Narrative
Amount available for equity commitments	$ 500,000	$ 500,000

Convertible Note Payable (Detai

Convertible Note Payable (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Interest expense related to issuance Notes	$ 125,347	$ 42,018
Amortization of deferred financing cost	110,547	36,995
Deferred financing cost balance	17,008	127,555
Convertible debt balance	999,697	541,525
Debt discount	92,803	550,975
Accrued interest	158,997	39,917
Related Party [Member]
Deferred financing cost balance	458,172	112,704
Convertible debt balance	52,615	28,501
Debt discount	4,885	28,999
Accrued interest	$ 8,368	$ 2,101

Notes Payable (Details Narrativ

Notes Payable (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 30, 2015	Dec. 31, 2014	Dec. 30, 2014
Interest expense related to issuance Notes	$ 125,347		$ 42,018
Amortization of deferred financing cost	110,547		36,995
Deferred financing cost balance	17,008		127,555
Convertible debt balance	999,697		541,525
Debt discount	92,803		550,975
Accrued interest	158,997		39,917
2015 Notes [Member]
Interest expense related to issuance Notes		$ 14,440		$ 0
Amortization of deferred financing cost		9,006		0
Deferred financing cost balance	40,869		$ 0
Amortization of debt discount		$ 51,826		$ 0
Convertible debt balance	194,177
Debt discount	175,823
Accrued interest	12,874
Related Party 2015 Notes [Member]
Convertible debt balance	29,757
Debt discount	15,247
Accrued interest	$ 1,565

Derivative Liability (Details)

Derivative Liability (Details)	12 Months Ended
	Dec. 31, 2015
Convertible Note [Member] | December 31, 2014 measurement [Member]
Stock price volatility	192.00%
Convertible Note [Member] | December 31, 2015 measurement [Member]
Stock price volatility	174.00%
Convertible Note [Member] | Probability of default triggering [Member]
Stock price volatility	0.00%
Warrant [Member] | December 31, 2015 measurement [Member]
Stock price volatility	174.00%
Warrant [Member] | December 31, 2014 [Member]
Stock price volatility	192.00%
Warrant [Member] | August 21, 2015 measurement [Member]
Stock price volatility	158.00%

Derivative Liability (Details 1

Derivative Liability (Details 1) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Derivative Liability Details 1
Derivative liability, Beginning Balance	$ 457,380
Debt discount		$ 295,773
Debt discount due to warrants issued with notes payable	179,106
Deferred financing cost due to derivative liability for placement agent warrant		$ 29,550
Deferred financing cost originated from derivative liability	12,775	29,550
Gain on change of fair value	(224,226)	(114,848)
Derivative liability, Ending Balance	$ 425,035	$ 457,380

Derivative Liability (Details 2

Derivative Liability (Details 2)	12 Months Ended
	Dec. 31, 2015USD ($)$ / shares
Derivative Liability Details 2
Total # of warrants issued and outstanding | $	$ 32,613,551
Weighted-average exercise price	$ 0.12
Remaining life (in years)	2 years 7 months 2 days
Intrinsic value

Derivative Liability (Details N

Derivative Liability (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Derivative Liability Details Narrative
Exercise price	$ 0.15	$ 0.15
Warrants issued to investor due to reset features	1,430,134	1,418,987
Derivative liability	$ 425,035	$ 457,380
Gain (loss) on derivative liability	$ 224,226	$ 114,848

Income Taxes (Details)

Income Taxes (Details) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Income Taxes Details
Deferred tax asset	$ 20,138,621	$ 19,161,984
Less: Valuation allowance	(20,138,621)	(19,161,984)
Deferred tax liability	$ 723,000	$ 723,000

Income Taxes (Details Narrative

Income Taxes (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Income Taxes Details
Net Operative Loss carry forward	$ 50,100,000	$ 47,900,000
Expiration starting year	2,017

Lease Commitments (Details)

Lease Commitments (Details)	Dec. 31, 2015USD ($)
Lease Commitments Details
2,016	$ 49,874
2,017	17,918
2,018	1,764
2,019	$ 882
2,020
Total minimum lease payments	$ 70,438

Lease Commitments (Details Narr

Lease Commitments (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Lease Commitments Details
Rent expense	$ 44,706	$ 43,937

Accounts Payable (Details Narra

Accounts Payable (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Accounts Payable Details Narrative
Gain on accounts payable write off		$ (59,899)

Inventory Write Off (Details Na

Inventory Write Off (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Inventory Write Off Details Narrative
Loss on inventory write off	$ 44,518

Legal Proceedings (Details Narr

Legal Proceedings (Details Narrative) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Legal Proceedings Details Narrative
Other accrued expenses	$ 190,000	$ 190,000